New York, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Pharmaceutical API Manufacturing Global Market Report 2023" - https ...
As pharmaceutical companies increasingly seek resilient and flexible supply chains, WuXi AppTec is expanding manufacturing capabilities across the United States, Europe, and Asia with a focus on ...
The global biotech API manufacturing services market, valued at US$ 38.9 Billion in 2022, is projected to grow at a CAGR of 7.1% from 2023 to 2031, surpassing US$ 73 Billion by 2031. biotech API ...
Efficiency and adaptability are crucial in the ever-evolving manufacturing industry. As manufacturers adopt advanced technologies like IoT, AI, and cloud computing, the need for seamless integration ...
Manufacturers in Europe and the United States have announced plans for new in-country API development and manufacturing capabilities. Manufacturers in Europe and the United States have announced plans ...
China and India, which are the largest producers of APIs for the U.S. drug supply, also account for most of the FDA regulatory actions. Not only do quality problems at Chinese and Indian firms raise ...
Just weeks after announcing a deal to sell its antibiotics manufacturing in the U.S. to Neopharma, India’s Dr. Reddy’s Laboratories says it will now unload its API manufacturing business in Jeedimetla ...
Axplora is strategically consolidating ursodeoxycholic acid (UDCA) manufacturing at its Vizag, India site, part of the ...
The shortage of Cisplatin and Carboplatin in India shows how geopolitical conflicts can disrupt global pharmaceutical supply ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results